CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Targovax ASA Company Snapshot
Targovax ASA operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Targovax ASA with three other miscellaneous service companies in Europe: Neurovive Pharmaceutical AB of Sweden (2016 sales of 14,000.00 Swedish Kronor [US$1,727.32 ] of which 100% was Neurostat), RELIEF THERAPEUTICS Holding SA of Switzerland (15,000.00 Swiss Francs [US$15,353.10 ] ), and Xintela AB which is based in Sweden (3,000.00 Swedish Kronor [US$370.14 ] ).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Targovax ASA
  Stock Performance Chart for Targovax ASA
 
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 21.25
(Figures in Norwegian Kroner)
1 Week 16.1%   13 Weeks 19.4%  
4 Weeks 20.1%   52 Weeks 83.1%  
 
Targovax ASA Key Data:
  Ticker: TRVX Country: Norway
  Exchanges: OSL Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 37,000
(Year Ending Jan 2017).
Employees: N/A
  Currency: Norwegian Kroner Market Cap: 1,116,993,096
  Fiscal Yr Ends: December Shares Outstanding: 52,564,381
  Share Type: Ordinary Closely Held Shares: 8,524,160
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.